Ypsomed Holding AG 2023 AR2
The report highlights Ypsomed Holding AG's sustainability and financial performance for the fiscal year 2022/23. The company advanced its climate program by submitting concrete reduction targets to the Science Based Targets initiative (SBTi) in spring 2023, aiming for net-zero emissions across its value chain by 2040. Ypsomed successfully certified its environmental management system under ISO 14001 and achieved ISCC+ certification for its Lochbach production site. Operationally, the company recorded a satisfying sales growth of CHF 32.6 million, with consolidated sales reaching CHF 497.5 million, driven by strong performance in its injection systems and diabetes care segments.
Company: Ypsomed Holding AG
Sector: Health Care
Country: Switzerland
Year: 2023
Type: AR2
Pages: 132
Ypsomed Holding AG
Annual Report
The report highlights Ypsomed Holding AG's sustainability and financial performance for the fiscal year 2022/23. The company advanced its climate program by submitting concrete reduction targets to the Science Based Targets initiative (SBTi) in spring 2023, aiming for net-zero emissions across its value chain by 2040. Ypsomed successfully certified its environmental management system under ISO 14001 and achieved ISCC+ certification for its Lochbach production site. Operationally, the company recorded a satisfying sales growth of CHF 32.6 million, with consolidated sales reaching CHF 497.5 million, driven by strong performance in its injection systems and diabetes care segments.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees